It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Boris Johnson to begin trade talks with U.S. in two weeks, Telegraph reports

Business Feb 24, 2020

Boris Johnson to begin trade talks with U.S. in two weeks, Telegraph reports

British Prime Minister Boris Johnson is prepared to begin trade talks with the United States within the coming two weeks, the Telegraph reported on Sunday. The British government's "red lines" for the trade negotiations, due to be published next week, are expected to push back ...

National / Science & Health Feb 22, 2020

Tosoh working on chemical reagent that could slash COVID-19 detection times

Chemical maker Tosoh Corp. said it has begun developing a reagent that can detect the new coronavirus in less than 50 minutes, slashing the six-hour waiting time required by current test kits. While it usually takes about two years to commercialize an agent, Tokyo-based Tosoh ...

National / Science & Health Feb 22, 2020

Japan might approve anti-flu drug Avigan to treat coronavirus patients

Japan is considering using Avigan, an influenza medication developed by a unit of Fujifilm Holdings Corp., to treat patients of the novel coronavirus, health minister Katsunobu Kato says.

As COVID-19 spreads, Takeda CEO urges more industry investment in vaccines

Business / Corporate Feb 20, 2020

As COVID-19 spreads, Takeda CEO urges more industry investment in vaccines

by Lisa Du

The spread of novel coronavirus infections is starting to make one thing clear: More vaccine investment is needed, the CEO of Asia's biggest drugmaker said. "The world has to be more proactive than reactive," Christophe Weber, CEO of Takeda Pharmaceutical Co., said in an interview. Although ...

In fighting outbreaks like COVID-19, Big Pharma struggles to get out front

World / Science & Health Feb 19, 2020

In fighting outbreaks like COVID-19, Big Pharma struggles to get out front

Sanofi has joined the race to combat coronavirus as the outbreak is kindling fears of a pandemic. The question is whether its effort will prove more effective than some of Big Pharma's past attempts to tackle dangerous new pathogens. The French drugmaker said Tuesday it ...

Lung biopsy of deceased China patient shows SARS-like damage

Asia Pacific / Science & Health Feb 18, 2020

Lung biopsy of deceased China patient shows SARS-like damage

by Jason Gale

Doctors studying a 50-year-old man who died in China last month from the new coronavirus found that the disease caused lung damage reminiscent of two prior coronavirus-related outbreaks, SARS and MERS. The patient died on Jan. 27 after a two-week illness that left him increasingly ...

Gilead drug prevents type of coronavirus in monkeys, raising hope for China trials

Asia Pacific / Science & Health Feb 14, 2020

Gilead drug prevents type of coronavirus in monkeys, raising hope for China trials

An experimental Gilead Sciences antiviral drug prevented disease and reduced the severity of symptoms in monkeys infected with Middle East respiratory syndrome (MERS), an infection closely related to the fast-spreading coronavirus that originated in China, a study published on Thursday found. The results, reported in ...

Results from Chinese drug trials for coronavirus due in weeks: expert

Asia Pacific / Science & Health Feb 13, 2020

Results from Chinese drug trials for coronavirus due in weeks: expert

Chinese scientists are testing two antiviral drugs against the new coronavirus and preliminary clinical trial results are weeks away, the co-chair of a World Health Organization (WHO) meeting said on Wednesday. Dr. Marie-Paule Kieny, a former WHO virologist, co-chaired the two-day, closed-door research forum in ...

Drugmakers see long road ahead in coronavirus vaccine race

Asia Pacific / Science & Health Feb 6, 2020

Drugmakers see long road ahead in coronavirus vaccine race

Drugmakers racing to find a vaccine or effective treatment for the deadly new coronavirus cautioned that they have a long way to go. That runs counter to reports of a supposed "breakthrough" that on Wednesday boosted financial markets and spurred optimism not necessarily backed by ...

White House scraps key plan to lower U.S. drug prices, may target makers

Business Jul 12, 2019

White House scraps key plan to lower U.S. drug prices, may target makers

The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing down from a policy aimed at health insurers and raising the possibility of new measures focused on drug makers. The abandoned proposal would have required health insurers ...

Eroding trust in vaccines leaves populations vulnerable, global study finds

World / Science & Health Jun 20, 2019

Eroding trust in vaccines leaves populations vulnerable, global study finds

Trust in vaccines — one of the world's most effective and widely-used medical products — is highest in poorer countries but weaker in wealthier ones where skepticism has allowed outbreaks of diseases such as measles to persist, a global study released Wednesday has found. France ...

World / Science & Health May 16, 2019

Scientists launch push to beat cancer's ability to adapt against treatments

Cancer scientists in Britain are launching what they call the world's first "Darwinian" drug development program in a bid to get ahead of cancer's ability to become resistant to even the newest treatments and recur in many patients. While not abandoning the search for an ...

« 1 … 36 37 38 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times